1 |
CH0113817123 |
Bellevue Biotech DT CHF |
+0,34 % |
+18,48 % |
-0,11 |
2 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-2,74 % |
+18,53 % |
-0,27 |
3 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-2,96 % |
+18,51 % |
-0,29 |
4 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
-3,07 % |
+18,37 % |
-0,29 |
5 |
LU0133360163 |
Candriam Equities L Biotechnology, I - Capitalisation |
-3,17 % |
+18,33 % |
-0,30 |
|
44 |
LU0976566496 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse W (acc) USD |
-10,20 % |
+19,62 % |
-0,64 |
|
73 |
DE000DWS2UA1 |
DWS ESG Biotech TFC |
-15,07 % |
+20,03 % |
-0,87 |
74 |
LU0959058974 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 |
-14,74 % |
+19,63 % |
-0,87 |
75 |
LU1991432631 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK |
-17,13 % |
+20,73 % |
-0,94 |
76 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-32,28 % |
+30,22 % |
-1,14 |
77 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-32,35 % |
+30,21 % |
-1,15 |